Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Oral Oncology|September 20, 2011
Radical radiotherapy for nasopharyngeal carcinoma in elderly patients: the importance of co-morbidity assessmentHenry C K Sze, W T Ng, Oscar S H Chan, et al.
Oncogene|November 6, 2007
Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cellsS Uttamsingh, X Bao, K T Nguyen, et al.
The Journal of Investigative Dermatology|May 28, 2010
The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cellsMaithao N Le, Joseph L-K Chan, Stephen A Rosenberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1996
p53 mutational spectrum of esophageal carcinomas from five different geographical locales in ChinaM L Lung, W C Chan, Y S Zong, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|December 3, 2002
Prone table stereotactic breast biopsyJ Y H Hui, L K Chan, R L M Chan, et al.
Frontiers in Psychology|July 18, 2022
Evaluating the Effectiveness of Digital Content Marketing Under Mixed Reality Training Platform on the Online Purchase IntentionC H Li, O L K Chan, Y T Chow, et al.
Pigment Cell & Melanoma Research|April 12, 2011
Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibitionKarine A Cohen-Solal, Kim T Merrigan, Joseph L-K Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2011
Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapiesHwa Jin Lee, Brian A Wall, Janet Wangari-Talbot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2009
A phase 0 trial of riluzole in patients with resectable stage III and IV melanomaDana Yip, Maithao N Le, Joseph L-K Chan, et al.
Translational Oncology|March 10, 2015
Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma ProgressionStephen A Rosenberg, Scot A Niglio, Negar Salehomoum, et al.
Pageof 13